Clinical trial
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT00005804 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00005804 |
|---|---|
| Title | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer |
| Official title | Treatment of Patients With Hematological Malignancies Using Marrow Transplantation From Unrelated Donors Incompatible for One HLA Locus Antigen |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous/Nonmalignant Condition, Small Intestine Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cyclophosphamide, allogeneic bone marrow transplantation, radiation therapy |
| Start date | Oct 1, 1999 |
| Primary completion | Aug 1, 2002 |
| Completion | Aug 1, 2002 |
| First posted | Aug 28, 2003 |
| Last update posted | Apr 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: